Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

Since the onset of the COVID-19 pandemic, significant progress has been made in
developing effective preventive and therapeutic strategies against severe acute SARS-CoV …

SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin-
converting enzyme 2 (ACE2) and results in the production of multiple proinflammatory …

SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin
converting enzyme 2 (ACE2) on target cells and results in acute symptoms involving …

Transactive response DNA binding protein 43 kDa (TDP-43) was discovered in 2001 as a
cellular factor capable to inhibit HIV-1 gene expression. Successively, it was brought to new …

Although there are indications of a trend towards less severe acute respiratory symptoms
and a decline in overall lethality from the novel Coronavirus Disease 2019 (COVID-19) …

The transactive response DNA-binding protein (TARDBP/TDP-43) is known to stabilize the
anti-HIV-1 factor, histone deacetylase 6 (HDAC6). TDP-43 has been reported to determine …

Simple Summary In this study, we investigated the long-term effects of COVID-19 on the
kidneys using mice infected with a similar coronavirus. We examined markers in the kidneys …

Gastrointestinal (GI) infection is evidenced with involvement in COVID-19 pathogenesis
caused by SARS-CoV-2. However, the correlation between GI microbiota and the distinct …

Systemic inflammation may trigger innate immune memory and persistent changes in
hematopoietic cells through epigenetic mechanisms, though investigating these phenotypes …